• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肝细胞癌（HCC）诊断与管理中的影像学及影像引导介入——证据综述

Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.

作者信息

Ghanaati Hossein, Alavian Seyed Moayed, Jafarian Ali, Ebrahimi Daryani Nasser, Nassiri-Toosi Mohsen, Jalali Amir Hossein, Shakiba Madjid

机构信息

Department of Radiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran ; Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Iran J Radiol. 2012 Nov;9(4):167-77. doi: 10.5812/iranjradiol.8242. Epub 2012 Nov 20.

DOI:10.5812/iranjradiol.8242
PMID:23407596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3569547/
Abstract

The imaging of hepatocellular carcinoma (HCC) is challenging and plays a crucial role in the diagnosis and staging of the disease. A variety of imaging modalities, such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine are currently used in evaluating patients with HCC. Although the best option for the treatment of these cases is hepatic resection or transplantation, only 20% of HCCs are surgically treatable. In those patients who are not eligible for surgical treatment, interventional therapies such as transcatheter arterial chemoembolization (TACE), percutaneous ethanol injection (PEI), radio-frequency ablation (RFA), percutaneous microwave coagulation therapy (PMC), laser ablation or cryoablation, and acetic acid injection are indicated. In this paper, we aimed to review the evidence regarding imaging modalities and therapeutic interventions of HCC.

摘要

肝细胞癌（HCC）的影像学检查具有挑战性，在该疾病的诊断和分期中起着关键作用。目前，多种影像学检查方法，如超声、计算机断层扫描（CT）、磁共振成像（MRI）和核医学，被用于评估HCC患者。尽管这些病例的最佳治疗选择是肝切除或肝移植，但只有20%的HCC可通过手术治疗。对于那些不符合手术治疗条件的患者，可采用介入治疗，如经动脉化疗栓塞（TACE）、经皮乙醇注射（PEI）、射频消融（RFA）、经皮微波凝固治疗（PMC）、激光消融或冷冻消融以及醋酸注射。在本文中，我们旨在综述有关HCC影像学检查方法和治疗干预措施的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/3dfa01ab2035/iranjradiol-09-167-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/23a12dfac66b/iranjradiol-09-167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/0da127e26f0e/iranjradiol-09-167-i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/2946a51dc2b2/iranjradiol-09-167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/ee7ebdb65ff4/iranjradiol-09-167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/3dfa01ab2035/iranjradiol-09-167-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/23a12dfac66b/iranjradiol-09-167-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/0da127e26f0e/iranjradiol-09-167-i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/2946a51dc2b2/iranjradiol-09-167-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/ee7ebdb65ff4/iranjradiol-09-167-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a829/3569547/3dfa01ab2035/iranjradiol-09-167-g004.jpg

相似文献

1
Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence.肝细胞癌（HCC）诊断与管理中的影像学及影像引导介入——证据综述
Iran J Radiol. 2012 Nov;9(4):167-77. doi: 10.5812/iranjradiol.8242. Epub 2012 Nov 20.
2
Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up.经介入治疗的肝细胞癌：CT与MRI随访
World J Gastroenterol. 2004 Dec 15;10(24):3543-8. doi: 10.3748/wjg.v10.i24.3543.
3
Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.经皮微波消融联合经皮乙醇注射治疗胆囊旁肝细胞癌的安全性评估及疗效观察
Int J Hyperthermia. 2015 Feb;31(1):40-7. doi: 10.3109/02656736.2014.999017. Epub 2015 Mar 13.
4
Interventional radiology for hepatocellular carcinoma.肝细胞癌的介入放射学
Minerva Gastroenterol Dietol. 2011 Sep;57(3):299-309.
5
Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.利用磁共振扩散加权成像和计算机断层扫描灌注成像评估经导管动脉化疗栓塞联合计算机断层扫描引导下射频消融治疗肝细胞癌的疗效：一项前瞻性研究。
Medicine (Baltimore). 2017 Jan;96(3):e5518. doi: 10.1097/MD.0000000000005518.
6
Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.肝细胞癌区域和局部消融治疗的结果：一项综合综述。
Eur J Surg Oncol. 2005 May;31(4):331-47. doi: 10.1016/j.ejso.2004.10.011.
7
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.射频（热）消融术与不干预或其他干预措施治疗肝细胞癌的比较
Cochrane Database Syst Rev. 2013 Dec 19;2013(12):CD003046. doi: 10.1002/14651858.CD003046.pub3.
8
[Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].经动脉化疗栓塞术后联合经皮射频消融与经皮乙醇注射治疗肝细胞癌的评估
Zhonghua Zhong Liu Za Zhi. 2005 Apr;27(4):248-50.
9
Interventional treatments for hepatocellular carcinoma.肝细胞癌的介入治疗
Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):495-500.
10
Role of local ablative therapy for hepatocellular carcinoma.局部消融治疗在肝细胞癌中的作用。
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S104-11. doi: 10.1016/j.jceh.2014.03.046. Epub 2014 Apr 1.

引用本文的文献

1
Integrative analysis of bulk and single-cell transcriptomic data reveals novel insights into lipid metabolism and prognostic factors in hepatocellular carcinoma.对批量和单细胞转录组数据的综合分析揭示了肝细胞癌脂质代谢和预后因素的新见解。
Discov Oncol. 2024 Oct 25;15(1):591. doi: 10.1007/s12672-024-01487-y.
2
Assessment of Systemic Toxicity, Genotoxicity, and Early Phase Hepatocarcinogenicity of Iron (III)-Tannic Acid Nanoparticles in Rats.铁（III）-单宁酸纳米颗粒对大鼠的全身毒性、遗传毒性及早期肝癌致癌性评估
Nanomaterials (Basel). 2022 Mar 22;12(7):1040. doi: 10.3390/nano12071040.
3
Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.

本文引用的文献

1
Nintinol self-expandable metallic stenting in management of malignant obstructive jaundice: a case series.镍钛诺自膨式金属支架治疗恶性梗阻性黄疸：病例系列
Hepat Mon. 2010 Winter;10(1):57-61. Epub 2010 Mar 1.
2
Risk factors and incidence of hepatocellular carcinoma in Southeast Iran.伊朗东南部肝细胞癌的危险因素与发病率
Hepat Mon. 2011 Aug;11(8):666-7. doi: 10.5812/kowsar.1735143x.710.
3
Advances of interventional radiology in treatment of hepatobiliary diseases in Iran.伊朗介入放射学在肝胆疾病治疗中的进展
UGP2 低表达与肿瘤进展相关，并预测肝细胞癌预后不良。
Dis Markers. 2020 Jul 11;2020:3231273. doi: 10.1155/2020/3231273. eCollection 2020.
4
Feasibility of hyperspectral analysis for discrimination of rabbit liver VX2 tumor.高光谱分析用于鉴别兔肝VX2肿瘤的可行性
World J Gastrointest Oncol. 2019 Jan 15;11(1):1-8. doi: 10.4251/wjgo.v11.i1.1.
5
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.从肝癌的诊断到治疗：发达国家和发展中国家共同面临的流行问题。
World J Gastroenterol. 2017 Aug 7;23(29):5282-5294. doi: 10.3748/wjg.v23.i29.5282.
6
Preliminary results of ultrasound-guided laser ablation for unresectable metastases to retroperitoneal and hepatic portal lymph nodes.超声引导下激光消融治疗腹膜后及肝门淋巴结不可切除转移瘤的初步结果
World J Surg Oncol. 2016 Jun 23;14(1):165. doi: 10.1186/s12957-016-0917-2.
7
Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine-induced killer cell therapy in hepatobiliary and pancreatic cancer.树突状细胞疫苗联合细胞因子诱导的杀伤细胞疗法治疗肝胆胰癌的临床疗效
Mol Clin Oncol. 2016 Jan;4(1):129-133. doi: 10.3892/mco.2015.660. Epub 2015 Oct 23.
8
Assessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study.基于光谱计算机断层扫描成像的碘基材料分解图像评估经动脉化疗栓塞术后肝细胞癌的碘油沉积及残留癌：一项初步研究
Iran J Radiol. 2015 Aug 5;12(4):e26009. doi: 10.5812/iranjradiol.26009. eCollection 2015 Oct.
9
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.经皮微波消融与射频消融治疗肝细胞癌的对比
World J Hepatol. 2015 May 18;7(8):1054-63. doi: 10.4254/wjh.v7.i8.1054.
10
Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma.经导管动脉化疗栓塞术治疗不可切除肝细胞癌患者。
Hepat Mon. 2014 Dec 28;14(12):e25792. doi: 10.5812/hepatmon.25792. eCollection 2014 Dec.
Hepat Mon. 2011 Jul;11(7):507-10.
4
The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran.伊朗马什哈德普通人群中乙肝抗原阳性的患病率。
Hepat Mon. 2011 May;11(5):346-50.
5
Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?: Hepatocellular recurrence after orthotopic liver trasplantation.原位肝移植后肝细胞复发：甲胎蛋白和磷脂酰肌醇蛋白聚糖-3联合检测是否为可靠标志物？：原位肝移植后肝细胞复发
Hepat Mon. 2011 Mar;11(3):155-6.
6
Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis.乙型肝炎病毒的基因型、突变、病毒载量与肝细胞癌风险：乙肝病毒特性与肝癌发生
Hepat Mon. 2011 Feb;11(2):86-91.
7
Hepatocellular carcinoma: HCC.肝细胞癌：HCC。
Hepat Mon. 2011 Feb;11(2):69-70.
8
Epidemiology and management of hepatocellular carcinoma.肝细胞癌的流行病学和管理。
Infect Dis Clin North Am. 2010 Dec;24(4):899-919, viii. doi: 10.1016/j.idc.2010.07.004.
9
Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010.射频消融治疗肝细胞癌：2010 年最新综述。
Oncology. 2010 Jul;78 Suppl 1:113-24. doi: 10.1159/000315239. Epub 2010 Jul 8.
10
Advances of imaging for hepatocellular carcinoma.肝细胞癌的影像学进展。
Oncology. 2010 Jul;78 Suppl 1:46-52. doi: 10.1159/000315230. Epub 2010 Jul 8.